Canadian Active & Maintenance Modified Pentasa Study

NCT00603733 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

288

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Ulcerative Colitis
Remission of Ulcerative Colitis

Interventions

DRUG: 5-ASA (5-Aminosalicylate)
DRUG: 5-ASA (5-Aminosalicylate)

Sponsor

Ferring Pharmaceuticals